Cargando…

Relevance of the drug–drug interactions between lidocaine and the pharmacokinetic enhancers ritonavir and cobicistat

Detalles Bibliográficos
Autores principales: Dekkers, Bart G.J., Bierman, Wouter F.W., Touw, Daan J., Alffenaar, Jan-Willem C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6467581/
https://www.ncbi.nlm.nih.gov/pubmed/30946167
http://dx.doi.org/10.1097/QAD.0000000000002162
_version_ 1783411289140232192
author Dekkers, Bart G.J.
Bierman, Wouter F.W.
Touw, Daan J.
Alffenaar, Jan-Willem C.
author_facet Dekkers, Bart G.J.
Bierman, Wouter F.W.
Touw, Daan J.
Alffenaar, Jan-Willem C.
author_sort Dekkers, Bart G.J.
collection PubMed
description
format Online
Article
Text
id pubmed-6467581
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-64675812019-05-29 Relevance of the drug–drug interactions between lidocaine and the pharmacokinetic enhancers ritonavir and cobicistat Dekkers, Bart G.J. Bierman, Wouter F.W. Touw, Daan J. Alffenaar, Jan-Willem C. AIDS Correspondence Lippincott Williams & Wilkins 2019-05-01 2019-02-07 /pmc/articles/PMC6467581/ /pubmed/30946167 http://dx.doi.org/10.1097/QAD.0000000000002162 Text en Copyright © 2019 The Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by-nc-nd/4.0 This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0
spellingShingle Correspondence
Dekkers, Bart G.J.
Bierman, Wouter F.W.
Touw, Daan J.
Alffenaar, Jan-Willem C.
Relevance of the drug–drug interactions between lidocaine and the pharmacokinetic enhancers ritonavir and cobicistat
title Relevance of the drug–drug interactions between lidocaine and the pharmacokinetic enhancers ritonavir and cobicistat
title_full Relevance of the drug–drug interactions between lidocaine and the pharmacokinetic enhancers ritonavir and cobicistat
title_fullStr Relevance of the drug–drug interactions between lidocaine and the pharmacokinetic enhancers ritonavir and cobicistat
title_full_unstemmed Relevance of the drug–drug interactions between lidocaine and the pharmacokinetic enhancers ritonavir and cobicistat
title_short Relevance of the drug–drug interactions between lidocaine and the pharmacokinetic enhancers ritonavir and cobicistat
title_sort relevance of the drug–drug interactions between lidocaine and the pharmacokinetic enhancers ritonavir and cobicistat
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6467581/
https://www.ncbi.nlm.nih.gov/pubmed/30946167
http://dx.doi.org/10.1097/QAD.0000000000002162
work_keys_str_mv AT dekkersbartgj relevanceofthedrugdruginteractionsbetweenlidocaineandthepharmacokineticenhancersritonavirandcobicistat
AT biermanwouterfw relevanceofthedrugdruginteractionsbetweenlidocaineandthepharmacokineticenhancersritonavirandcobicistat
AT touwdaanj relevanceofthedrugdruginteractionsbetweenlidocaineandthepharmacokineticenhancersritonavirandcobicistat
AT alffenaarjanwillemc relevanceofthedrugdruginteractionsbetweenlidocaineandthepharmacokineticenhancersritonavirandcobicistat